BRAF and melanoma: We confirmed the positive BRAF mutational status obtained with our previous results (Supplementary Table 1, Table 2), in primary melanoma at high rates (30, 47 and 41 % of mutated alleles, respectively) and lack of BRAF mutation in the metastatic samples (Figure 2A, 2C, 2D).